HopeStage
Back to all studies
TerminatedNCT02357849

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

Medication studyAges 12–25United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 12 years to 25 years.

Listed locations
Glen OaksSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJuly 2014
Recruitment status
Terminated
Enrollment listed in the registry
9
Sponsor
Northwell Health
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 12 Years to 25 Years
Official registry ID
NCT02357849
Official title
Show the full official title

The Role of Antidepressants or Antipsychotics in Preventing Psychosis: Fluoxetine vs Aripiprazole Comparative Trial (FACT)

Questions about this study?

The HopeStage team will email you.

Loading the security check...

Recruitment & locations

Terminated

Glen Oaks

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Northwell Health.

Does this study involve medication?

Yes. The study involves medication, including Aripiprazole and Fluoxetine.

Who can participate?

Listed age limits: 12 years to 25 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me